Aventis Pasteur
77Patents
2Active
77Granted
34Portfolio score
Filing activity: Jun 16, 1994 → Feb 4, 2010 · 2 expiring within 5 years
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6471996B1 | Biodegradable targetable microparticle delivery system | Emerging Cross-Sectional Technologies | 81 | Expired |
| US6146902A | Purification of polysaccharide-protein conjugate vaccines by ultrafiltration with ammonium sulfate solutions | Emerging Cross-Sectional Technologies | 72 | Expired |
| US7018637B2 | Multi-oligosaccharide glycoconjugate bacterial meningitis vaccines | Emerging Cross-Sectional Technologies | 54 | Expired |
| US6309647A | Poxvirus--canine dispemper virus (CDV) or measles virus recombinants and compositions and methods employing the recombinants | Chemistry; Metallurgy | 29 | Expired |
| US6656472B1 | Multi oligosaccharide glycoconjugate bacterial meningitis vaccines | Emerging Cross-Sectional Technologies | 28 | Expired |
| US6780407B1 | Pox virus comprising DNA sequences encoding CEA and B7 antigen | Chemistry; Metallurgy | 24 | Expired |
| US6348198B1 | Lactoferrin receptor protein | Emerging Cross-Sectional Technologies | 20 | Expired |
| US6538123B2 | Vaccine composition for preventing or treating hepatitis C | Emerging Cross-Sectional Technologies | 16 | Expired |
| US6693087B1 | Nucleic acid molecules encoding POMP91A protein of Chlamydia | Human Necessities | 14 | Expired |
| US6486135B1 | Nucleic acid respiratory syncytial virus vaccines | Chemistry; Metallurgy | 14 | Expired |
| US6521745B1 | Nucleic acid molecules encoding inclusion membrane protein C of Chlamydia | Human Necessities | 14 | Expired |
| US6808713B1 | Chlamydia antigens and corresponding DNA fragments and uses thereof | Emerging Cross-Sectional Technologies | 13 | Expired |
| US6623764B1 | Biodegradable targetable microparticle delivery system | Emerging Cross-Sectional Technologies | 12 | Expired |
| US6544527B1 | Non-infectious, immunogenic, human immunodeficiency virus-like particles devoid of long terminal repeats and a functional pol coding region | Chemistry; Metallurgy | 11 | Expired |
| US7008784B1 | Non-infectious, non-replicating, immunogenic human immunodeficiency virus-like particles | Emerging Cross-Sectional Technologies | 11 | Expired |
| US7241449B1 | Transferrin receptor genes of moraxella | Human Necessities | 10 | Expired |
| US6335018B1 | High molecular weight major outer membrane protein of moraxella | Emerging Cross-Sectional Technologies | 9 | Expired |
| US6399076B2 | Acellular pertussis vaccines and methods of preparation thereof | Emerging Cross-Sectional Technologies | 8 | Expired |
| US6291208A | Chimeric antibodies for delivery of antigens to selected cells of the immune system | Chemistry; Metallurgy | 8 | Expired |
| US6764682B1 | Adjuvant compositions containing more than one adjuvant | Chemistry; Metallurgy | 8 | Expired |
| US6437096B1 | Transferrin receptor of moraxella | Human Necessities | 5 | Expired |
| US6544752B1 | Anigenically-marked non-infectious retrovirus-like particles | Chemistry; Metallurgy | 5 | Expired |
| US6440424B1 | High molecular weight major outer membrane protein of moraxella | Emerging Cross-Sectional Technologies | 4 | Expired |
| US6503514B1 | Attenuated strains of mycobacteria | Emerging Cross-Sectional Technologies | 4 | Expired |
| US6440425B1 | High molecular weight major outer membrane protein of moraxella | Emerging Cross-Sectional Technologies | 4 | Expired |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.